Inactief instrument

Koers Ocata Therapeutics Inc

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	10-02-16
Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	22-01-16
Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	28-12-15
Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	03-12-15
OCATA THERAPEUTICS : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Astellas Pharma Inc.	11-11-15

Managers	Titel	Leeftijd	Van
Yoshitsuga Shitaka PSD	President	-	-
John Heffernan PRN	Corporate Officer/Principal	-	03-02-15

Besturend	Titel	Leeftijd	Van
Percival Barretto-Ko BRD	Director/Board Member	51	-
Masaaki Hirano BRD	Director/Board Member	57	-
Toru Yoshimitsu BRD	Director/Board Member	61	-

Sector

	Vaira. 1 jan.	Kapi.
VERTEX PHARMACEUTICALS INCORPORATED	-2,31%	103 mld.
REGENERON PHARMACEUTICALS, INC.	+0,56%	95,28 mld.
ARGENX SE	+1,69%	22,15 mld.
BIONTECH SE	-17,37%	21,02 mld.
GENMAB A/S	-9,30%	18,15 mld.
WUXI APPTEC CO., LTD.	-41,01%	16,74 mld.
BEIGENE, LTD.	-14,85%	16,05 mld.
NEUROCRINE BIOSCIENCES, INC.	+3,21%	13,68 mld.
SAREPTA THERAPEUTICS, INC.	+33,54%	12,17 mld.